Guangzhou BoWeiTai ShengWuGongSiRetatrutide
Ordered Retatrutide from Guangzhou BoWeiTai ShengWuGongSi? Mail in a sample (US only) and let us test it.
Test my supplyGuangzhou BoWeiTai Retatrutide has clean but narrow evidence: 99.9% purity, identity pass, negative endotoxins, and fills at -3% and -7%. Same-batch, same-day vendor-sent tests and no price or review corroboration keep uncertainty elevated.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Guangzhou BoWeiTai ShengWuGongSi rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 2 Nov 2026 | Pass | n8vgym8 Tested | lab name | View COA | |||
| 2 Nov 2026 | Pass | k3daufj Tested | lab name | View COA | |||
About Guangzhou BoWeiTai ShengWuGongSi test results from Finnrick
Guangzhou BoWeiTai ShengWuGongSi is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 2 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Guangzhou BoWeiTai ShengWuGongSi peptides in this dataset are Retatrutide (2 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 2 recent tests.
Ordered Retatrutide from Guangzhou BoWeiTai ShengWuGongSi? Mail in a sample (US only) and let us test it.
Test my supply